IntoCell인투셀
287840 · KOSDAQ · ₩287840 · 인투셀
₩15,980▼ ₩120 (0.75%)End-of-day · Oct 27, 2026 · End-of-day prices.
Filings
- Investor relations (IR) event기업설명회(IR)개최Aug 18, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (Nectin-4 단백질 표적 고형암 치료제 후보물질 SBE303에 대한 ADC 플랫폼기술 이전계약 체결)Jul 22, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 5, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 5, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 26, 2026Open on DART
- Audit report submitted감사보고서제출Mar 18, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 18, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 11, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 11, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 10, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 11, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 2, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인) (ITC6146RO의 한국 MFDS 임상1상 임상시험계획을 미국 FDA 승인된 최종 임상시험계획서와 동일하게 변경 신청하여 승인됨)Dec 29, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Dec 24, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 15, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최Dec 10, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인신청) (ITC6146RO의 한국 MFDS 임상1상 임상시험계획을 미국 FDA 승인된 최종 임상시험계획서와 동일하게 변경 신청)Dec 4, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청등결정) (ITC6146RO의 한국 MFDS 제1상 임상시험계획 승인)Dec 1, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청등결정) (ITC6146RO의 미국FDA 제1상 임상시험계획 승인)Nov 27, 2025Open on DART
- [Amended Filing] Exercise of Stock Subscription Warrants[기재정정]신주인수권행사Nov 21, 2025Open on DART
- Exercise of Subscription Rights for New Shares신주인수권행사Nov 14, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청) ((ITC6146RO의 미국 FDA 제1상 임상시험계획 승인신청))Oct 31, 2025Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Oct 30, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청) (ITC6146RO의 한국 MFDS 제1상 임상시험계획 승인신청)Aug 29, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 16, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (ADC 플랫폼 기술에 대한 실시권 계약 해지)Jul 9, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 7, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Jun 23, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)May 30, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)May 29, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)May 29, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 28, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 28, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 28, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 28, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 28, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 28, 2025Open on DART
- Securities Issuance Results Report증권발행실적보고서May 16, 2025Open on DART
- Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)May 12, 2025Open on DART
- Amended: Prospectus[기재정정]투자설명서May 12, 2025Open on DART
- Terms set: Securities registration statement[발행조건확정]증권신고서(지분증권)May 12, 2025Open on DART
- Prospectus투자설명서May 7, 2025Open on DART
- Amended: Securities registration statement[기재정정]증권신고서(지분증권)May 2, 2025Open on DART
- Amended: Securities registration statement[기재정정]증권신고서(지분증권)Apr 10, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: IntoCell / 인투셀 / 287840 / KRX:287840
Source: KRX statistical information